Analysen von James Quigley
| 11.03.25 | Merck Buy | Goldman Sachs Group Inc. | |
| 11.03.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 11.03.25 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 06.03.25 | Merck Buy | Goldman Sachs Group Inc. | |
| 05.03.25 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 19.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 19.02.25 | Merck Buy | Goldman Sachs Group Inc. | |
| 11.02.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 10.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 10.02.25 | Merck Buy | Goldman Sachs Group Inc. | |
| 10.02.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 06.02.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 06.02.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 05.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 31.01.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 30.01.25 | Sartorius Stedim Biotech Buy | Goldman Sachs Group Inc. | |
| 30.01.25 | Sartorius vz. Neutral | Goldman Sachs Group Inc. | |
| 30.01.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 24.01.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 14.01.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 10.01.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 09.01.25 | Sartorius Stedim Biotech Buy | Goldman Sachs Group Inc. | |
| 09.01.25 | Sartorius vz. Neutral | Goldman Sachs Group Inc. | |
| 09.01.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 09.01.25 | Merck Buy | Goldman Sachs Group Inc. | |
| 19.12.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 27.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 26.11.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 22.11.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 21.11.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 15.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 15.11.24 | Merck Buy | Goldman Sachs Group Inc. | |
| 14.11.24 | Merck Buy | Goldman Sachs Group Inc. | |
| 13.11.24 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 12.11.24 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 12.11.24 | Merck Buy | Goldman Sachs Group Inc. | |
| 11.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 06.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 04.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 31.10.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 29.10.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 17.10.24 | Merck Buy | Goldman Sachs Group Inc. | |
| 17.10.24 | Sartorius Stedim Biotech Buy | Goldman Sachs Group Inc. | |
| 17.10.24 | Sartorius vz. Neutral | Goldman Sachs Group Inc. | |
| 11.10.24 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 11.10.24 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 03.10.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 03.10.24 | Sartorius Stedim Biotech Buy | Goldman Sachs Group Inc. | |
| 03.10.24 | Sartorius vz. Neutral | Goldman Sachs Group Inc. | |
| 02.10.24 | Novartis Neutral | Goldman Sachs Group Inc. | |